跳至主要内容
临床试验/CTRI/2020/12/029979
CTRI/2020/12/029979已完成2 期

Clinical evaluation of the effect on oral administration of ELATHI CHOORANAM along with external administration of KAIYANTHAGARAI TAILAM in the management of VADHAPEENISAM.

Dr S Vidhya Rajeswari1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年12月29日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Decreases the frequency of sneezing, prolonged running nose, nasal congestion and other clinical symptpoms.

研究概览

简要总结

It is a single arm clinical trial to determine the safety and efficacy of ELATHI CHOORANAM(oral administration) along with KAIYANTHAGARAI TAILAM (external administration) in patients with VADHAPEENISAM. The outcome will measured by day 1,week 1 week 2, week 3 intervals.During this period if any adverse effect and serious adverse effect will be noticed and referred to pharmacovigilance department in Government siddha medical college and hospital, Palayamkottai and for the management will also be given in department of Kuzhanthai maruthuvam OPD and IPD. After the completion of trial all the study related data will be analyzed statistically.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
7.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Subjects with any of the following symptoms will be included in the study 1.Pain and swelling of the maxillary region 2.Frequent Sneezing with seasonal allergy 3.Frequent focusing for allergy 4.Prolonged running nose(Rhinitis).

排除标准

  • 1.Children below 7 years and above 12 years 2.Severe and recurrent epistaxis due to rhinitis 3.Rhinisporidiasis 4.TB rhinitis 5.Severe form of DNS(Deviated Nasal Septum).

结局指标

主要结局

Decreases the frequency of sneezing, prolonged running nose, nasal congestion and other clinical symptpoms.

时间窗: 21 days

次要结局

未报告次要终点

研究者

发起方
Dr S Vidhya Rajeswari
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验